|
|
||||||||
Clinical Investigations |
1 Department of Radiology, Osaka City University School of Medicine, Osaka, Japan
2 Department of Nuclear Medicine, Osaka City University School of Medicine, Osaka, Japan
3 Department of Obstetrics and Gynecology, Osaka City University School of Medicine, Osaka, Japan
The purpose of this study was to evaluate PET using 18F-FDG for gynecologic lesions with continuous bladder irrigation to eliminate artifacts from the 18F-FDG activity in the bladder. Methods: Forty-one patients were studied. They had 23 cervical uterine lesions (15 cases of cancer, 5 recurrences, 3 nonrecurrences); 8 cases of uterine corpus cancer, including 2 recurrences; and 10 ovarian masses (6 malignant, 4 nonmalignant). All cases of cancer were histologically proven; however, 2 cases of nonrecurrent uterine cervical carcinomas were diagnosed by clinical course. Continuous bladder irrigation was performed 3555 min after intravenous administration of 185370 MBq 18F-FDG, and an emission scan was obtained 4055 min after intravenous administration. Standardized uptake value (SUV) was used to estimate the degree of 18F-FDG uptake quantitatively. Results: After bladder irrigation, the 18F-FDG activity in the urinary tract was eliminated in 33 patients, so that detection of tumor 18F-FDG accumulation was easy. Two patients showed residual activity in the urinary bladder, and 6 patients showed activity in the ureter. An artifact was seen in 1 patient with residual activity in the urinary bladder caused by insufficient irrigation. However, these residual activities had no influence on detecting 18F-FDG accumulation in tumor. The mean (±SD) of SUVs of malignant lesions was 6.04 ± 3.22, that of nonmalignant lesions was 1.71 ± 1.12, and the difference was significant (P = 0.0002). SUVs of all malignant lesions were greater than 2.0, and SUVs of all nonmalignant lesions, except the 1 case of ovarian fibroma, were less than 2.0. Conclusion: 18F-FDG PET with continuous bladder irrigation is useful for eliminating 18F-FDG activity in the bladder and for differentiating between malignant and nonmalignant uterine or ovarian masses.
Key Words: 18F-FDG PET bladder irrigation uterine cancer ovarian tumor MRI
This article has been cited by other articles:
![]() |
D. D. Purcell, F. V. Coakley, B. L. Franc, R. A. Hawkins, S. E. Boddington, and B. M. Yeh Anterior Layering of Excreted 18F-FDG in the Bladder on PET/CT: Frequency and Cause Am. J. Roentgenol., August 1, 2007; 189(2): W96 - W99. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Anjos, E. C.S.C. Etchebehere, C. D. Ramos, A. O. Santos, C. Albertotti, and E. E. Camargo 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer J. Nucl. Med., May 1, 2007; 48(5): 764 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Kamel, P. Jichlinski, J. O. Prior, J.-Y. Meuwly, J.-F. Delaloye, L. Vaucher, J. Malterre, S. Castaldo, H.-J. Leisinger, and A. B. Delaloye Forced Diuresis Improves the Diagnostic Accuracy of 18F-FDG PET in Abdominopelvic Malignancies J. Nucl. Med., November 1, 2006; 47(11): 1803 - 1807. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |